Supplementary table to Bennett et al. Peripheral arterial disease and Virchow s triad (Thromb Haemost 2009; 101.6)

Similar documents
The Study of Endothelial Function in CKD and ESRD

Classification of Endothelial Dysfunction. Stefano Taddei Department of Internal Medicine University of Pisa, Italy

Dyslipidemia Endothelial dysfunction Free radicals Immunologic

Introduction. Risk factors of PVD 5/8/2017

Thrombophilia. Diagnosis and Management. Kevin P. Hubbard, DO, FACOI

VENOUS THROMBOEMBOLISM AND CORONARY ARTERY DISEASE: IS THERE A LINK?

Cho et al., 2009 Journal of Cardiology (2009), 54:

Peripheral Arterial Disease Extremity

Is there an association between atherosclerosis and chronic venous disease?

Peripheral Arterial Disease (PAD): Presentation, Diagnosis, and Treatment

Choosing Study Outcomes that Reflect Cardiovascular Disease: From Biomarkers to Burden of Disease. Greg Wellenius Joel Kaufman

Part IV Antithrombotics, Anticoagulants and Fibrinolytics

What are blood clots?

Treatment Strategies For Patients with Peripheral Artery Disease

Downloaded from ismj.bpums.ac.ir at 4: on Monday January 7th (In-Stent Restenosis) :

Intima-Media Thickness

LIBERTY 360 Study. 15-Jun-2018 Data 1. Olinic Dm, et al. Int Angiol. 2018;37:

Jordan M. Garrison, MD FACS, FASMBS

Objectives. Abdominal Aortic Aneuryms 11/16/2017. The Vascular Patient: Diagnosis and Conservative Treatment

Berries and Cardiovascular Health

Complications of Diabetes mellitus. Dr Bill Young 16 March 2015

Blood coagulation and fibrinolysis. Blood clotting (HAP unit 5 th )

ATHEROSCLEROSIS زيد ثامر جابر. Zaid. Th. Jaber

Thrombophilia. Dr. A Sarrafnejad PhD Dep. Immunology School of public health TUMS

Learning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship

Peripheral Arterial Disease

Annals of RSCB Vol. XVI, Issue 1

Biochemical Reaction Networks and Blood Clotting

Approach to Thrombosis

The Struggle to Manage Stroke, Aneurysm and PAD

The association of the total cardiovascular risk and non-invasive markers of atherosclerosis with the extent of coronary artery disease

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

Arteriopatie periferiche. Trattamento delle arteriopatie periferiche: AVK versus Antiaggregante

La Trombosi Arteriosa

A study on diabetic foot and its association with peripheral artery disease

Ch. 45 Blood Plasma proteins, Coagulation and Fibrinolysis Student Learning Outcomes: Describe basic components of plasma

All biomarkers at higher level in HIV group

Subclavian artery Stenting

Endothelial dysfunction and subclinical atherosclerosis in HIV/HCV- coinfected patients in the Lower Silesia Region, Poland

Menopausal Hormone Therapy & Haemostasis

The Changing Landscape of Managing Patients with PAD- Update on the Evidence and Practice of Care in Patients with Peripheral Artery Disease

Hemodynamic Disorders, Thromboembolic Disease, and Shock

Antiplatelet agents treatment

National Vascular Registry

Supplemental Figures and Legends

Antithrombotic therapy in the ACS patient with atrial fibrillation

Peripheral Vascular Disease

Diagnosis and Management of Acute Myocardial Infarction

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center

Peripheral Arterial Occlusive Disease- The Challenge in patients with diabetes

(For items 1-12, each question specifies mark one or mark all that apply.)

ACC NY Cardiovascular Symposium

Peripheral Arterial Disease: Who has it and what to do about it?

ARIC Manuscript Proposal # PC Reviewed: 05/12/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

Peripheral Vascular Disease Patient Awareness

7 th Munich Vascular Conference

To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events.

Thrombosis. Jeffrey Jhang, M.D.

Pathophysiology. Tutorial 3 Hemodynamic Disorders

THROMBOSIS. Dr. Nisreen Abu Shahin Assistant Professor of Pathology Pathology Department University of Jordan

Diagnosis of hypercoagulability is by. Molecular markers

FACTOR Xa AND PAR-1 BLOCKER : ATLAS-2, APPRAISE-2 & TRACER TRIALS

HEART HEALTH WEEK 2 SUPPLEMENT. A Beginner s Guide to Cardiovascular Disease ATHEROSCLEROSIS. Fatty deposits can narrow and harden the artery

Hemodynamic Disorders, Thrombosis, and Shock. Richard A. McPherson, M.D.

Thrombosis. By Dr. Sara Mohamed Abuelgasim

Practical Point in Diabetic Foot Care 3-4 July 2017

When referring to this work, the full bibliographic details must be given as follows:

PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN

Genetics of Arterial and Venous Thrombosis: Clinical Aspects and a Look to the Future

Lessons & Perspectives: What is the role of Cryoplasty in SFA Intervention?

Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial

Primary Exam Physiology lecture 5. Haemostasis

Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE)

DISSEMINATED INTRAVASCULAR COAGULATION (DIC) Pichika Chantrathammachart MD Division of Hematology, Department of Medicine Ramathibodi Hospital

Haemostasis, thrombosis risk and hormone replacement therapy

Critical Limb Ischemia A Collaborative Approach to Patient Care. Christopher LeSar, MD Vascular Institute of Chattanooga July 28, 2017

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary

UTHEALTH HOUSTON CCTS BIOBANK VARIABLE LIST

OUTPATIENT DEPARTMENT

Platelet function in diabetes

Inflammation plays a major role in atherosclerosis, 1 and

Placebo-Controlled Statin Trials

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

Peripheral Artery Disease Role of Exercise, Endovascular and Surgical Options

Lipoprotein (a) Disclosures 2/20/2013. Lipoprotein (a): Should We Measure? Should We Treat? Health Diagnostic Laboratory, Inc. No other disclosures

Supplementary Appendix

Diabetic Patients: Current Evidence of Revascularization

ATHEROSCLEROSIS. Secondary changes are found in other coats of the vessel wall.

The presenter does not have any potential conflicts of interest to disclose

Post Operative Troponin Leak: David Smyth Christchurch New Zealand

PERIPHERAL ARTERIAL DISEASE: INCIDENCE, RISK FACTORS, AND DIAGNOSIS. Andrew Althouse. B.S., Carnegie Mellon University, 2008

Pathology of Cardiovascular Interventions. Body and Disease 2011

Introduction to coagulation and laboratory tests

Peripheral Arterial Disease. Westley Smith MD Vascular Fellow

Outline Anti-coagulant and anti-thrombotic drugs Haemostasis and Thrombosis Year 3 Dentistry

NHS Dumfries & Galloway Aspirin Discontinuation Audit May 2011 (updated August 2015)

Study population Patients with intermittent claudication or critical ischaemia due to an iliac arterial stenosis.

Atherectomy: Jetstream and Directional. George S. Chrysant, M.D.

Transcription:

Supplementary table to ennett et al. Peripheral arterial disease and Virchow s triad (Thromb Haemost 2009; 101.6) Supplementary Table 1: Examples of Recent studies reporting positive associations between components of Virchow s Triad and peripheral arterial disease Components of Virchow s Triad: : bnormal blood vessel wall : bnormal blood constituents C: bnormal blood flow PI: ankle brachial pressure index; : peripheral arterial disease; IC: intermittent claudication; CLI: critical limb ischaemia; MI: myocardial infarction; TI: transient ischaemic attack; CD: coronary artery disease; : abdominal aortic aneurysm; MI: body mass index; PT: percutaneous transluminal angioplasty; TF: tissue factor; TFPI: tissue factor pathway inhibitor; CRP: C-reactive protein; IL: interleukin; VCM-1: vascular adhesion molecule-1; ICM-1: intercellular adhesion molecule-1; Hcy: homocysteine; PI-1: plasminogen activator inhibitor-1; tp: tissue plasminogen activator; TM: thrombomodulin; S: serum amyloid ; IMT: intima medial thickness; Ix: aortic index; P-sel: p-selectin; VWF: von Willebrand factor; Lp(a): lipoprotein (a); TT: thrombin antithrombin three; PM; platelet microaggregates, MCP-1: monocyte chemoattractant protein-1; PMP: platelet microparticles; WSS: wall shear stress, CEC: circulating endothelial cells; Hct: haematocrit. Study & Population Khaleghi et al. 2009[151] 1051 frican mericans, 894 Non-Hispanic Whites artlett et al. 2009[99] 785 men with Gosk-ierska et al. 2008[152] 62 patients with IC, 20 controls McDermott et al. 2008[153] 423 patients with Markers Studied Fibrinogen, d- dimer, Factors V, VII, VIII, VWF, ntithrombin III Fibrinogen TF, TFPI D-dimer, CRP, IL- 6, VCM-1, ICM-1, Hcy Summary of significant (P<0.5) associations Elevated fibrinogen and d-dimer were the only markers independently associated with lower PI in frican mericans and Non-Hispanic Whites aseline fibrinogen was an independent predictor of all-cause mortality risk. dding fibrinogen to a set of other risk factors did not improve predictive ability. Patients with had higher TF, total TFPI and truncated TFPI than controls. Full-length TFPI was lower in patients with than in controls Elevated levels of all of these factors were associated with poorer 6 minute walking performance. Increased d-dimer, IL-6, VCM-1 and Hcy were associated with slower usual paced Components of Virchow s Triad,,

Mota et al. 2008[105] 36 patients with, 30 Controls Heneghan et al. 2008[135] 225 patients with CLI undergoing revascularisation procedures Hogh et al. 2008[128] 452 patients with symptomatic Vidula et al. 2008[154] 377 patients with Sodhi et al. 2007[155] 195 patients >40 years free from cardiovascular disease and symptomatic Khaleghi et al. 2007[77] 475 Patients with rewer et al. 2007[78] 106 Patients with Rajagapolan et al. 2007[79] 182 patients with symptomatic D-dimer, plasminogen, prothrombin fragment 1 & 2, PI-1, TM Hcy CRP D-dimer, CRP, S IMT Ix. Ix. P-Sel Fibrinogen 4 metre walking speed Patients had higher levels than controls. Inverse correlations between plasminogen and PI-1 Patients with raised Hcy had significantly lower primary, assisted primary and secondary patency rates at all intervals to 36 months. Mean amputation survival was lower in patients with raised Hcy CRP levels were higher overall among patients developing primary endpoints (death, lower limb amputation, peripheral revascularisation) or secondary endpoint (thrombosis of lower limbs, MI, stroke, TI) Higher levels of these factors was associated with higher all cause and higher cardiovascular mortality among patients who died within 1 st 2 years of measurement in people with There was a significant correlation between PI and common carotid IMT Ix. Was independently associated with lower PI; association modified by age High Ix associated with lower walking distance in people with Patients with sub-critical limb ischaemia had significantly enhanced DP stimulation, P-Sel expression and bound fibrinogen. lso had higher TRP platelet aggregation,

Cleanthis et al. 2007[156] 19 patients with IC and 10 patinets with CLI taking aspirin 12 controls not on aspirin Tzoulaki et al. 2007[56] 1519 men & women Iwashima et al. 2006[54] 40 patients with 48 controls llison et al. 2006[125] 6814 men and women free from clinically apparent cardiovascular disease PM, P-Sel, MCP- 1 CRP, fibrinogen, Lp(a), Hct, IL-6, ICM-1, VCM- 1, blood viscosity. plasma viscosity, tp ICM-1, VCM- 1, diponectin, CRP IL-6, fibrinogen, d- dimer, Hcy, VWF P-Sel, PM and MCP-1 were all higher in CLI compared to IC and controls despite aspirin CRP, fibrinogen, Lp(a) and Hct were significantly associated with after 17 years follow up. Significant trend between higher levels of ICM-1, D-dimer, tp and Hct and worsening disease from no disease to moderate (IC) and severe (CLI or surgical intervention). IL-6, ICM-1, Lp(a), fibrinogen, tp and D- dimer and al rheological markers were significantly elevated at baseline in patients who experienced symptomatic during 17 year follow up. diponectin was lower in than without. diponectin, sicm-1, svcm-1, hscrp were independently associated with PI IL-6, fibrinogen, d-dimer and Hcy were all significantly associated with after adjustment for transitional cardiovascular risk factors,, C, Kals et al. 2006[73] 38 Patients with 28 Controls rterial elasticity, oxidative stress Patients with had decreased large and small artery elasticity. Decreased arterial elasticity and high grade oxidative stress was found in patients with atherosclerosis., C Spring et al. 2006[146] 31 Patients with WSS, erythrocyte aggregation, leucocyte count, fibrinogen, plasma WSS was lower in patients with and than in controls. WSS was inversely related to erythrocyte aggregation,,, C

31 patients with 37 Controls revetti et al. 2006[157 154 patients with Unlu et al. 2006[158] 45 patients with 44 controls Kudoh et al. 2006[85] 42 patients with CD and 56 CD only 32 controls Laxdal et al. 2006[98] 139 vascular interventions on 103 patients with common iliac occlusive disease McDermott et al. 2005[66] 6570 men and women free from clinically evident disease viscosity, IMT CRP, metabolic syndrome D-dimer, CRP, fibrinogen, S fibrinogen, leucocyte count, plasma viscosity and IMT. Metabolic syndrome was present in 51.9% of patients. Patients with an PI <0.64 were more likely to have metabolic syndrome than those with less severe. patients with metabolic syndrome had higher MI & CRP than those without. D-dimer, CRP, S were higher in group than control group. associated with moderately higher fibrinogen. CRP & serum amyloid had an inverse relationship with PI. D-dimer & fibrinogen were related to lower PI Platelet aggregation The level of small platelet aggregates was increased significantly in the group compared with both CD and control groups. Platelet aggregability was increased in patients with with the degree of platelet aggregation being closely related to PI Hcy, fibrinogen, d- dimer, activated protein C resistance IMT There was a significant association between patency rate and levels of fibrinogen, Hcy. The highest values of Hcy and fibrinogen were independent predictors of failure Men and women with definite, borderline PI or lownormal PI had significantly higher internal CIMT than those with normal PI. In men the association between PI and internal CIMT were significantly less inverse in Caucasians than in frican mericans Cassar et al. 2005[29] CRP, VWF, d- dimer, TT CRP, vwf, d-dimer and TT were significantly raised in patients with IC compared to,

132 patients with IC 30 CLI 40 controls controls. Patients with CLI had significantly higher levels of CRP, VWF, and TT than claudicants Sofi et al. 2005[159] 280 patients with symptomatic 280 controls Tan et al. 2005[88] 23 patients with CLI 36 with IC 30 controls PI-1, Lp(a), Hcy, factor V leiden mutation, prothrombin variant Platelets, P-sel, PMP There was an association between symptoms and prothrombin variant, altered levels of homocysteine, Lp(a), PI-1 and P. The presence of Lp(a) and another metabolic antibody increased the risk of symptoms. There was a correlation between the number of altered thrombophilic factors and Fontaine stage of. PMPs were increased relatively to healthy controls in patients with IC and further increased in critical limb ischaemia. Platelets and sp- Sel independently predict severity on multivariate analysis Wildman et al. 2005[160] 4787 men and women Urge et al. 2005[161 37 Diabetic patients with Makin et al. 2004[48] 20 patients in each group of ischaemic rest pain, acute MI, stable IC, healthy controls Lee et al. 2004[58] 33 patients admitted for elective PT CRP, fibrinogen, leucocyte count Hct CEC, TF, VWF VCM-1, ICM- 1, P-sel, CRP On multivariate analysis there were significantly higher odds of developing in the highest compared to the lowest quartiles of CRP, fibrinogen and leucocyte count levels Increase in claudication distance correlated with haematocrit decrease in diabetic patients with peripheral vascular disease. Increased number of CECs and elevated TF and vwf in patients with ischaemic rest pain compared to those with IC and healthy controls. VCM-1, ICM-1 and hscrp were all higher and P-sel significantly lower in patients with systemic arterial disease. P- Selectin, VCM-1, hscrp were elevated significantly for at least 2 weeks post PT/stenting C,

Tseng et al. 2004[120] 557 patients with type II diabetes Parsson et al. 2004[162] 40 patients with CLI undergoing either femoropopliteal or femoro-distal recontruction Riba et al. 2004[127] 39 patients with IC 14 controls Koscielney et al. 2004[163] 2821 men and women Lp(a) tp, PI-1, d- dimer, IL-6, IL-2 rec, MCP-1, IL-10, TT Hcy Hct, plasma viscosity, fibrinogen, erythrocyte aggregation PI was associated with log [Lp(a)] especially in men or in patients with.. Lp(a) levels increased from no to mild and severe. Patients with CLI had increased IL-6, IL-2 receptor, TT, tp, D- dimer and fibrinogen prior to revascularisation. Elevated tp and D-dimer were found after 30 days posoperatively. Increased IL- 6, IL-10, MCP-1 was observed after reperfusion but normalised after 30 days. 63% of patients with were found to be mildly hyperhomocysteinaemic. Claudicants with elevated homocysteine had altered platelet function compared to controls In males with, Hct, plasma viscosity, fibrinogen and erythrocyte aggregation were significantly higher than controls., C